NO20080440L - Non-steroidal progesterone receptor modulators - Google Patents

Non-steroidal progesterone receptor modulators

Info

Publication number
NO20080440L
NO20080440L NO20080440A NO20080440A NO20080440L NO 20080440 L NO20080440 L NO 20080440L NO 20080440 A NO20080440 A NO 20080440A NO 20080440 A NO20080440 A NO 20080440A NO 20080440 L NO20080440 L NO 20080440L
Authority
NO
Norway
Prior art keywords
receptor modulators
progesterone receptor
therapy
prophylaxis
compounds
Prior art date
Application number
NO20080440A
Other languages
Norwegian (no)
Inventor
Ulrike Fuhrmann
Wolfgang Schwede
Lothar Sobek
Peter Droescher
Alexander Hillisch
Norbert Schmees
Ulrich Bothe
Guenter Kaufmann
Carsten Moeller
Anja Schmidt
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20080440L publication Critical patent/NO20080440L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/021,2-Oxazines; Hydrogenated 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse vedrører ikke-steroide progesteronreseptormodulatorer med generell formel (I), en fremgangsmåte for deres fremstilling, anvendelsen av progesteronreseptormodulatorene for fremstilling av medikamenter og farmasøytiske preparater som omfatter disse forbindelsene. Forbindelsene ifølge oppfinnelsen er passende for terapien og profylaksen av gynekologiske forstyrrelser slik som endometriose, leiomyomer i livmoren, feilaktig blødning og dysmenoré og til terapien og profylaksen av hormonavhengige tumorer og til anvendelse for kvinnelig fertilitetskontroll og til hormonerstatningsterapi.The present invention relates to non-steroidal progesterone receptor modulators of general formula (I), a process for their preparation, the use of the progesterone receptor modulators for the preparation of drugs and pharmaceutical compositions comprising these compounds. The compounds of the invention are suitable for the therapy and prophylaxis of gynecological disorders such as endometriosis, uterine leiomyomas, erroneous bleeding and dysmenorrhea, and for the therapy and prophylaxis of hormone dependent tumors and for use in female fertility control and hormone replacement therapy.

NO20080440A 2005-06-24 2008-01-23 Non-steroidal progesterone receptor modulators NO20080440L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005030292A DE102005030292A1 (en) 2005-06-24 2005-06-24 Nonsteroidal progesterone receptor modulators
PCT/EP2006/006531 WO2006136461A2 (en) 2005-06-24 2006-06-22 Non-steroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
NO20080440L true NO20080440L (en) 2008-03-25

Family

ID=37199176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080440A NO20080440L (en) 2005-06-24 2008-01-23 Non-steroidal progesterone receptor modulators

Country Status (22)

Country Link
EP (1) EP1902049A2 (en)
JP (1) JP2008543910A (en)
KR (1) KR20080030622A (en)
CN (1) CN101248066A (en)
AR (1) AR054519A1 (en)
AU (1) AU2006261048A1 (en)
BR (1) BRPI0611903A2 (en)
CA (1) CA2611897A1 (en)
CR (1) CR9598A (en)
DE (1) DE102005030292A1 (en)
DO (1) DOP2006000148A (en)
EA (1) EA200702524A1 (en)
EC (1) ECSP078044A (en)
GT (1) GT200600271A (en)
IL (1) IL188021A0 (en)
MX (1) MX2008000072A (en)
NO (1) NO20080440L (en)
PE (1) PE20070125A1 (en)
TW (1) TW200740778A (en)
UY (1) UY29624A1 (en)
WO (1) WO2006136461A2 (en)
ZA (1) ZA200800690B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (en) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
DE102007032800A1 (en) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nonsteroidal progesterone receptor modulators
DE102007058747A1 (en) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nonsteroidal progesterone receptor modulators
JP2011519916A (en) * 2008-07-02 2011-07-14 ファーマコステック カンパニー リミテッド Method for producing amide derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (en) * 1998-11-27 2000-05-31 Schering Ag Nonsteroidal anti-inflammatories
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
BRPI0412231A (en) * 2003-07-01 2006-08-22 Schering Ag heterocyclically substituted pentanol derivatives, processes for their preparation and application as inflammation inhibitors

Also Published As

Publication number Publication date
CR9598A (en) 2008-04-09
EP1902049A2 (en) 2008-03-26
PE20070125A1 (en) 2007-02-14
KR20080030622A (en) 2008-04-04
EA200702524A1 (en) 2008-06-30
BRPI0611903A2 (en) 2010-10-05
TW200740778A (en) 2007-11-01
CN101248066A (en) 2008-08-20
JP2008543910A (en) 2008-12-04
MX2008000072A (en) 2008-03-24
GT200600271A (en) 2007-02-05
ECSP078044A (en) 2008-01-23
WO2006136461A2 (en) 2006-12-28
WO2006136461A3 (en) 2007-03-15
DE102005030292A1 (en) 2007-01-11
DOP2006000148A (en) 2007-07-15
UY29624A1 (en) 2007-01-31
CA2611897A1 (en) 2006-12-28
IL188021A0 (en) 2008-03-20
ZA200800690B (en) 2009-09-30
AU2006261048A1 (en) 2006-12-28
AR054519A1 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
NO20090628L (en) Pyridizinone derivatives
TW200637874A (en) Peptides with neuropeptide-2 receptor (Y2R) agonist activity
BRPI0506721A (en) compound or an acid addition salt thereof
TW200806311A (en) Neuropeptide-2 receptor-agonists
NO20055852L (en) New peptides that bind to the erythropoietin receptor
EA200970835A1 (en) INDAZOLS APPLICABLE FOR THE TREATMENT OF DISORDERS MEDIATED BY ESTROGEN BETA RECEPTOR
NO20080441L (en) Benzofuranone derivatives as non-steroidal progesterone receptor modulators
NO20062679L (en) New 17β-hydroxysteroid dehydrogenase type 1 inhibitors
EA200970065A1 (en) DERIVATIVES OF PIPERAZINIL, INTENDED FOR THE TREATMENT OF DISEASES MEDIATED BY GPR38
BRPI0511466A (en) vasopressin receptor peptide agonists
TW200640863A (en) Compounds which potentiate glutamate receptor and uses thereof in medicine
NO20045217L (en) Use of thio-oxindole derivatives for the treatment of hormone-related conditions
EA200800421A1 (en) CONNECTIONS
NO20080394L (en) N- (arylalkyl) -1H-pyrrolopyridine-2-carboxamide derivatives, preparation and use thereof
NO20080440L (en) Non-steroidal progesterone receptor modulators
MY157425A (en) Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
DK1525215T3 (en) Modulators for the progesterone receptor with elevated anti-gonadotropic activity for women's fertility control and hormone replacement therapy
NO20090457L (en) Oxazolidone derivatives as PR modulators
UY29625A1 (en) USE OF NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
UA92500C2 (en) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
DK2200980T3 (en) Aminoarylsulfonamide compounds and their use as 5-HT6 ligands
WO2009071691A3 (en) Oxindole derivatives and the use thereof as a medication
WO2008113851A3 (en) Novel c11 modified retrosteroids as progesterone receptor modulator compounds
NO20061290L (en) New connections
WO2008077647A3 (en) Alpha- amino alcohols as non-steroidal progesterone receptor modulators

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application